Cas:24091-92-7 Methyl (2-bromo-4-chlorophenyl)acetate manufacturer & supplier

We serve Chemical Name:Methyl (2-bromo-4-chlorophenyl)acetate CAS:24091-92-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl (2-bromo-4-chlorophenyl)acetate

Chemical Name:Methyl (2-bromo-4-chlorophenyl)acetate
CAS.NO:24091-92-7
Synonyms:Methyl bromo(4-chlorophenyl)acetate;Benzeneacetic acid, 2-bromo-4-chloro-, methyl ester;Methyl α-bromo-4-chlorobenzeneacetate;Methyl α-Bromo-4-chlorophenylacetate;N-methoxycarbonyl-2-benzylpyrrolidine;Methyl (2-bromo-4-chlorophenyl)acetate;α-Bromo-4-chlorophenylacetic acid methyl ester;Benzeneacetic acid, α-bromo-4-chloro-, methyl ester;MFCD06658159;methyl 2-benzylpyrrolidinecarboxylate;GR DYEVO1
Molecular Formula:C9H8BrClO2
Molecular Weight:263.516
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:288.9±25.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.566
PSA:26.30000
Exact Mass:261.939606
LogP:3.42

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Methyl bromo(4-chlorophenyl)acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,GR DYEVO1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl (2-bromo-4-chlorophenyl)acetate Use and application,MFCD06658159 technical grade,usp/ep/jp grade.


Related News: The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). pregnenolone 3,4,5-triiodobenzoat manufacturers As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. Methyl 2-[4-(2-thenoyl)-phenoxy]2-methyl-propionate suppliers Biocatalysis is widely recognized to be one of the most powerful tools for organic synthesis due to its green credentials and its exquisite regio-, enantio-, and stereoselectivities. 2-[4-benzooxazol-2-ylmethylene-2-(2,4-dinitro-phenyl)-5-methyl-2,4-dihydro-pyrazol-3-ylidenemethyl]-1-ethyl-quinolinium; iodide vendor & factory.